What one share of Pacific Biosciences of California holds
We are a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems.
Pacific Biosciences of California’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.52 |
|---|---|
| Profit | −$0.43 |
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$0.41 |
| Cash and investments | $0.20 |
| Debt | $2.07 |
| Book value | −$0.11 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $0.27 | −$173.03 | $10.21 | −$157.86 | — | −$349.45 |
| 2010 | $0.17 | −$14.10 | $0.53 | −$12.80 | — | — |
| 2011 | $0.63 | −$2.03 | $0.17 | −$2.08 | — | $3.48 |
| 2012 | $0.47 | −$1.70 | $0.03 | −$1.41 | — | $1.95 |
| 2013 | $0.45 | −$1.26 | $0.01 | −$0.49 | $0.00 | $1.04 |
| 2014 | $0.86 | −$0.94 | $0.02 | −$0.75 | $0.00 | $0.74 |
| 2015 | $1.23 | −$0.42 | $0.04 | −$0.67 | $0.00 | $0.92 |
| 2016 | $1.02 | −$0.83 | $0.09 | −$0.85 | $0.00 | $0.91 |
| 2017 | $0.88 | −$0.87 | $0.10 | −$0.74 | $0.00 | $0.74 |
| 2018 | $0.58 | −$0.76 | $0.01 | −$0.51 | $0.00 | $0.76 |
| 2019 | $0.60 | −$0.55 | $0.02 | −$0.53 | $0.00 | $0.36 |
| 2020 | $0.45 | $0.17 | $0.01 | $0.11 | $0.00 | $1.74 |
| 2021 | $0.64 | −$0.89 | $0.03 | −$0.57 | $0.00 | $3.58 |
| 2022 | $0.57 | −$1.40 | $0.07 | −$1.25 | $0.00 | $2.49 |
| 2023 | $0.79 | −$1.21 | $0.03 | −$1.06 | $0.00 | $2.62 |
| 2024 | $0.53 | −$1.59 | $0.02 | −$0.74 | $0.00 | $1.72 |
| 2025 | $0.53 | −$1.82 | $0.01 | −$0.38 | $0.00 | $0.02 |
Common questions about Pacific Biosciences of California
How much does one share of Pacific Biosciences of California earn?
Over the last 12 months, Pacific Biosciences of California lost $0.43 for each share on $0.52 of sales.
Does Pacific Biosciences of California pay a dividend?
Pacific Biosciences of California didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Pacific Biosciences of California’s book value per share?
Pacific Biosciences of California’s book value is negative (−$0.11 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Pacific Biosciences of California have?
Each share of Pacific Biosciences of California has $0.20 of cash and investments and $2.07 of debt, as of June 30, 2026.
What is Pacific Biosciences of California’s free cash flow per share?
−$0.41 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Pacific Biosciences of California bought back shares?
Pacific Biosciences of California’s share count rose about 59079% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.